Evommune, Inc. (EVMN)
12.26
+0.26
(+2.17%)
USD |
NYSE |
Sep 04, 16:00
12.26
0.00 (0.00%)
After-Hours: 19:32
Evommune Cash and Short Term Investments (Annual) : 149.20M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 149.20M |
| December 31, 2024 | 72.04M |
| Date | Value |
|---|---|
| December 31, 2023 | 79.08M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| MapLight Therapeutics, Inc. | 305.10M |
| Mineralys Therapeutics, Inc. | 656.64M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |